BIO-PATH HOLDINGS, INC. (BPTH) Form 8-K Material Events
BIO-PATH HOLDINGS, INC. (BPTH) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BPTH
CIK: 1133818
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: WY
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerBeth Baubie
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 1-SA | 2026-08-20 | 2026-08-19 | SEMI ANNUAL REPORT PURSUANT TO REGULATION A | 0001663577-26-000256 | View SEC Doc Filr Page |
| 253G2 | 2026-08-05 | — | OFFERING CIRCULAR SUPPLEMENT NO. 1 | 0001663577-26-000240 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-04-30 | FORM 8-K | 0001663577-26-000218 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-14 | FORM 8-K | 0001663577-26-000170 | View SEC Doc Filr Page |
| 15-12G | 2026-05-22 | — | FORM 15 | 0001663577-26-000165 | View SEC Doc Filr Page |
| 10-Q | 2026-05-20 | 2026-03-31 | FORM 10-Q | 0001663577-26-000156 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | FORM NT 10-Q | 0001663577-26-000143 | View SEC Doc Filr Page |
| 1-K | 2026-05-01 | 2025-12-31 | 1-K Filing | 0001663577-26-000123 | View SEC Doc Filr Page |
| QUALIF | 2026-04-28 | — | QUALIF Filing | 9999999994-26-000084 | View SEC Doc Filr Page |
| CORRESP | 2026-04-27 | — | CORRESP Filing | 0001663577-26-000118 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-01 | — | UPLOAD Filing | 0000000000-26-003337 | View SEC Doc Filr Page |
| 1-A | 2026-03-25 | — | 1-A Filing | 0001663577-26-000075 | View SEC Doc Filr Page |
| 8-K | 2026-03-20 | 2026-01-02 | FORM 8-K | 0001663577-26-000064 | View SEC Doc Filr Page |
| 1-Z | 2026-02-25 | — | 1-Z Filing | 0001663577-26-000050 | View SEC Doc Filr Page |
| 8-K | 2026-02-24 | 2026-01-02 | FORM 8-K | 0001663577-26-000046 | View SEC Doc Filr Page |
| 10-Q | 2026-01-13 | 2025-09-30 | FORM 10-Q | 0001663577-26-000009 | View SEC Doc Filr Page |
| NT 10-Q | 2025-11-17 | 2025-09-30 | EXTENSION | 0001663577-25-000332 | View SEC Doc Filr Page |
| 8-K | 2025-11-14 | 2025-11-04 | FORM 8-K | 0001663577-25-000317 | View SEC Doc Filr Page |
| 8-K | 2025-10-29 | 2025-10-22 | FORM 8-K | 0001663577-25-000303 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001558370-25-011591 | View SEC Doc Filr Page |
| 8-K | 2025-08-13 | 2025-08-13 | FORM 8-K | 0001104659-25-077665 | View SEC Doc Filr Page |
| 25-NSE | 2025-07-11 | — | 25-NSE Filing | 0001354457-25-000650 | View SEC Doc Filr Page |
| 8-K | 2025-06-24 | 2025-06-20 | 8-K | 0001558370-25-008814 | View SEC Doc Filr Page |
| 253G3 | 2025-06-02 | — | 253G3 | 0001104659-25-055486 | View SEC Doc Filr Page |
| QUALIF | 2025-05-29 | — | QUALIF Filing | 9999999994-25-000096 | View SEC Doc Filr Page |